drugset / Trial / NCT00510367

Primary Breast Cancer Occurring Concomitant With Pregnancy

NCT00510367

Phase 0 Completed 61 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn the results of multimodality (chemotherapy, surgery and radiation therapy) treatment of primary breast cancer that occurs at the same time as pregnancy. Researchers want to evaluate the outcome of labor and delivery as well as evaluate the long-term health outcomes of children exposed to chemotherapy while in their mother's womb.

Timeline

Start
2001-08-07
Primary completion
2020-07-08
Completion
2020-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 500 mg/m2 Intravenous
Subject Doxorubicin Other / unclassified 50 mg/m2 Intravenous
Subject fluorouracil Small molecule 500 mg/m2 Intravenous

Indications